NCT00981201 - Celecoxib as a Chemopreventive Agent in Current and Former Smokers | Biotech Hunter

Enrollment

219

Participants

Timeline

Start Date

November 30, 2001

Primary Completion Date

July 31, 2007

Study Completion Date

September 30, 2009

Conditions

SmokingPrevention

Interventions

DRUG

Celecoxib

"Months 1-3:~As of October, 2003, the starting dose for celecoxib will be 400 mg by mouth twice daily. (Note: Prior to October, 2003, the starting dose for celecoxib was 200 mg by mouth twice daily.)"

DRUG

Celecoxib

"Months 4-6:~As of October, 2003, the starting dose for celecoxib will be 400 mg by mouth twice daily. (Note: Prior to October, 2003, the starting dose for celecoxib was 200 mg by mouth twice daily.)"

DRUG

Placebo

"Months 1-3:~By mouth twice daily."

DRUG

Placebo

"Months 4-6:~By mouth twice daily."

Trial Locations (1)

77030

U.T. M.D. Anderson Cancer Center, Houston

All Listed Sponsors

lead

M.D. Anderson Cancer Center

OTHER